Synthetic Biologics

ax splitting wood
Biotech

Biotechs cut pipeline prospects to focus on priority programs

Preparing for a prolonged bear market, a raft of biotechs have decided candidates that looked good a few months ago are now an extravagance.
Nick Paul Taylor Aug 11, 2022 9:43am
stop sign knerri61Pixabay

Synthetic Biologics cans phase 2 IBS trial deemed likely to fail

Oct 2, 2020 10:25am
FDA

Synthetic Biologics loses breakthrough status

Apr 23, 2018 9:00am
Wall Street

Tiny Synthorx raises $10M for synthetic amino acid trials

Jul 20, 2016 4:02am